HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yan Zhan Selected Research

henagliflozin

1/2021Characterization and quantitative determination of henagliflozin metabolites in humans.
1/2021Tolerability, Pharmacokinetic, and Pharmacodynamic Profiles of Henagliflozin, a Novel Selective Inhibitor of Sodium-Glucose Cotransporter 2, in Healthy Subjects Following Single- and Multiple-dose Administration.
1/2021Effects of Food on the Pharmacokinetic Properties and Mass Balance of Henagliflozin in Healthy Male Volunteers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yan Zhan Research Topics

Disease

12Neoplasms (Cancer)
11/2022 - 02/2008
5Brain Injuries (Brain Injury)
01/2022 - 02/2010
5Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
01/2015 - 01/2011
4Traumatic Brain Injuries (Traumatic Brain Injury)
01/2022 - 06/2012
4COVID-19
09/2021 - 01/2020
4Type 2 Diabetes Mellitus (MODY)
01/2021 - 01/2019
3Hemifacial Spasm
01/2022 - 01/2021
3Brain Edema (Cerebral Edema)
06/2012 - 06/2011
2Lung Neoplasms (Lung Cancer)
01/2021 - 04/2020
2Glioma (Gliomas)
01/2020 - 02/2010
2Epilepsy (Aura)
01/2019 - 04/2014
2Seizures (Absence Seizure)
01/2019 - 08/2017
2Temporal Lobe Epilepsy
08/2017 - 04/2014
2Edema (Dropsy)
01/2015 - 06/2009
2Spinal Cord Injuries (Spinal Cord Injury)
02/2010 - 06/2009
1Human Influenza (Influenza)
12/2022
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2022
1Ovarian Neoplasms (Ovarian Cancer)
06/2022
1Triple Negative Breast Neoplasms
06/2022
1Hyperuricemia
01/2022
1Gout
01/2022
1Acute Coronary Syndrome
09/2021
1Parkinson Disease (Parkinson's Disease)
02/2021
1Fasciculation (Fasciculations)
02/2021
1Hypersensitivity (Allergy)
01/2021
1Mental Disorders (Mental Disorder)
01/2021
1Communicable Diseases (Infectious Diseases)
01/2021
1End Stage Liver Disease
12/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
1Stomach Neoplasms (Stomach Cancer)
01/2018
1Neurodegenerative Diseases (Neurodegenerative Disease)
08/2017
1Circulating Neoplastic Cells
01/2016
1Glioblastoma (Glioblastoma Multiforme)
01/2016
1Liver Cirrhosis (Hepatic Cirrhosis)
12/2015
1Infections
12/2015
1Chronic Hepatitis B
12/2015

Drug/Important Bio-Agent (IBA)

6Glucose (Dextrose)FDA LinkGeneric
01/2022 - 06/2011
5Proteins (Proteins, Gene)FDA Link
02/2021 - 02/2008
4Neuroprotective AgentsIBA
08/2017 - 06/2009
3Pharmaceutical PreparationsIBA
06/2022 - 04/2020
3Apolipoproteins E (ApoE)IBA
01/2022 - 01/2020
3ApolipoproteinsIBA
01/2022 - 01/2020
3SodiumIBA
01/2021 - 01/2011
3henagliflozinIBA
01/2021 - 01/2021
2Oxygen (Dioxygen)IBA
01/2022 - 02/2012
2Pentylenetetrazole (Metrazol)IBA
01/2019 - 08/2017
2AntioxidantsIBA
01/2016 - 06/2011
2TamoxifenFDA LinkGeneric
02/2010 - 06/2009
1COVID-19 VaccinesIBA
12/2022
1Biomarkers (Surrogate Marker)IBA
06/2022
16-methyladenineIBA
06/2022
1urate transporterIBA
01/2022
1Caspase 3 (Caspase-3)IBA
01/2022
1Cytochromes c (Cytochrome c)IBA
01/2022
1simmitecanIBA
11/2021
1chimmitecanIBA
11/2021
1methyl 2- (2- acetoxy- 6,7- dihydrothieno(3,2- c)pyridin- 5(4H)- yl)- 2- (2- chlorophenyl)acetateIBA
09/2021
1Neurotransmitter Agents (Neurotransmitter)IBA
02/2021
1Dopamine (Intropin)FDA LinkGeneric
02/2021
1Sodium-Glucose Transport ProteinsIBA
01/2021
1SymportersIBA
01/2021
1Troponin IIBA
01/2021
1Cephalosporins (Cephalosporin Antibiotics)IBA
01/2021
1Viral RNAIBA
01/2021
1remdesivirIBA
10/2020
1Heparin (Liquaemin)FDA LinkGeneric
04/2020
1adipic dihydrazideIBA
04/2020
1Paclitaxel (Taxol)FDA LinkGeneric
04/2020
1PlatinumIBA
01/2020
1Mechanistic Target of Rapamycin Complex 1IBA
01/2020
1InterferonsIBA
01/2020
1Indicators and Reagents (Reagents)IBA
01/2020
1Messenger RNA (mRNA)IBA
01/2020
1Glucagon-Like Peptide-1 ReceptorIBA
01/2019
1Anticonvulsants (Antiepileptic Drugs)IBA
01/2019
1Glucagon-Like Peptide 1 (GLP 1)IBA
01/2019
1molybdenum dioxideIBA
03/2018
1Tyrosine Kinase InhibitorsIBA
01/2018
1apatinibIBA
01/2018
1Calcineurin InhibitorsIBA
08/2017
1Tacrolimus (Prograf)FDA LinkGeneric
08/2017
1CalcineurinIBA
08/2017
1Adenosine Triphosphate (ATP)IBA
01/2016
1sulforaphaneIBA
01/2016
1SiliconIBA
01/2016
1PolymersIBA
01/2016
1HLA-DPB1 antigen (HLA DPB1)IBA
12/2015
1HLA-DP Antigens (HLA-DP)IBA
12/2015
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
01/2015
1Imatinib Mesylate (Gleevec)FDA Link
01/2015
1Pilocarpine (Ocusert)FDA LinkGeneric
04/2014
1HDL CholesterolIBA
01/2013

Therapy/Procedure

7Therapeutics
11/2022 - 06/2009
4Drug Therapy (Chemotherapy)
09/2021 - 01/2016
2Microvascular Decompression Surgery
01/2022 - 01/2021
1Precision Medicine
09/2021
1Nursing Care
01/2021
1Liver Transplantation
12/2020
1Activities of Daily Living (ADL)
12/2020
1Photothermal Therapy
03/2018